Clinical Significance of the Expression of c-Met in Thyroid Tumor |
Rho Young-Soo
(Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University)
Hwang Joon-Sik (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University) Kim Jin-Hwan (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University) Lim Young-Han (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University) Kim Seung-Tae (Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Hallym University) Cho Seong-Jin (Department of Pathology, College of Medicine, Hallym University) |
1 | Maeta H, Ohgi S, Terada T: Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Arch. 2001;438(2):121-128 DOI ScienceOn |
2 | Boix L, Rosa JL, Ventura F, et al: c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology. 1994;1:88-91 DOI |
3 | Rosen EM, Meromasky L, Setter E: Purified scatter factor stimulates epithelial and endothelial cell migration. Proc Soc Exp Biol Med. 1990;195:34-43 DOI |
4 | Lppolito A, Vella V. La Rossa GL: Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy. Thyroid. 2000;11(8):783-787 DOI ScienceOn |
5 | Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R: Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 2002;13:41-59 DOI ScienceOn |
6 | Ramirez R, Hsu D, Patel A: Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2000;53(5):635-644 DOI ScienceOn |
7 | Rygaard K, Nakamura T, Spang-Thomsen M: Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer. 1993;67(1):37-46 DOI ScienceOn |
8 | Fluge O, Haugen DR, Lillehaug JR, Varhaug JE: Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue. World J Surg. 2001;25:623-631 DOI ScienceOn |
9 | Rueo LP, Stoppaeeaior A, Ballarini F, Prat M: Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. J Pathol. 2001;194(1):4-8 DOI ScienceOn |
10 | Saji M, Westra WH, Chen H, et al: Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery. 1997;122:1137-1140 DOI ScienceOn |